The prediction of future metabolic risk by CRP might in part be accounted by its role as a proxy of insulin resistance in pregnancy, but it still offers the advantage of being a useful marker in pregnancy that does not need to be measured in a fasting state. This evidence concerns the gene CRP and Insulin resistance.